Shen Yinxing, Zhang Junqi, Hao Weiju, Wang Tong, Liu Jing, Xie Youhua, Xu Shouhong, Liu Honglai
State Key Laboratory for Advanced Materials, School of Chemistry and Molecular Engineering, East China University of Science and Technology.
Department of Medical Microbiology and Parasitology, Key Laboratory of Medical Molecular Virology of MOE/MOH, School of Basic Medical Sciences, Fudan University, Shanghai, People's Republic of China.
Int J Nanomedicine. 2018 Jan 25;13:537-553. doi: 10.2147/IJN.S149942. eCollection 2018.
Efficient delivery of nucleic acids into target cells is crucial for nucleic acid-based therapies. Various nucleic acid delivery systems have been developed, each with its own advantages and limitations. We previously developed a nanoparticle-based delivery system for small chemical drugs using pH-responsive PEG-PDPA-PEG polymer micelles as carriers. In this study, we extend the application of these pH-responsive micelle-like nanoparticles (MNPs) to deliver oligonucleotides. We demonstrate that the MNPs efficiently encapsulate and deliver oligonucleotides of different lengths (20-100 nt) into cells. The cargo oligonucleotides are rapidly released at pH 5.0. We prepared MNPs carrying a Texas red-fluorescently labeled anti-human epidermal growth factor receptor 2 (HER2) aptamer (HApt). Compared to free HApt, the HApt-MNPs resulted in significantly better cellular uptake, reduced cell viability, and increased apoptosis in SKBR3 breast cancer cells, which overexpress HER2. Moreover, HApt-MNPs were significantly less cytotoxic to MCF7 breast cancer cells, which express low levels of HER2. After cellular uptake, HApt-MNPs mainly accumulated in lysosomes; inhibition of lysosomal activity using bafilomycin A1 and LysoTracker Red staining confirmed that lysosomal activity and low pH were required for HApt-MNP accumulation and release. Furthermore, HER2 protein expression declined significantly following treatment with HApt-MNPs in SKBR3 cells, indicating that HApt-induced translocation of HER2 to lysosomes exerted a potent cytotoxic effect by altering signaling downstream of HER2. In conclusion, this pH-responsive and lysosome-targeting nanoparticle system can efficiently deliver oligonucleotides to specific target cells and has significant potential for nucleic acid-based cancer therapies.
将核酸有效递送至靶细胞对于基于核酸的治疗至关重要。人们已开发出各种核酸递送系统,每种系统都有其自身的优缺点。我们之前开发了一种基于纳米颗粒的小分子化学药物递送系统,使用pH响应性PEG-PDPA-PEG聚合物胶束作为载体。在本研究中,我们将这些pH响应性类胶束纳米颗粒(MNP)的应用扩展至递送寡核苷酸。我们证明,MNP能够有效地将不同长度(20 - 100 nt)的寡核苷酸封装并递送至细胞内。货物寡核苷酸在pH 5.0时快速释放。我们制备了携带德克萨斯红荧光标记的抗人表皮生长因子受体2(HER2)适配体(HApt)的MNP。与游离HApt相比,HApt-MNP在过表达HER2的SKBR3乳腺癌细胞中导致显著更好的细胞摄取、降低的细胞活力和增加的细胞凋亡。此外,HApt-MNP对低表达HER2的MCF7乳腺癌细胞的细胞毒性显著更低。细胞摄取后,HApt-MNP主要积聚在溶酶体中;使用巴弗洛霉素A1抑制溶酶体活性以及LysoTracker Red染色证实,溶酶体活性和低pH对于HApt-MNP的积聚和释放是必需的。此外,在SKBR3细胞中用HApt-MNP处理后,HER2蛋白表达显著下降,表明HApt诱导的HER2向溶酶体的易位通过改变HER2下游信号传导发挥了强大的细胞毒性作用。总之,这种pH响应性且靶向溶酶体的纳米颗粒系统能够有效地将寡核苷酸递送至特定靶细胞,并且在基于核酸的癌症治疗中具有巨大潜力。